We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDp Poland Regulatory News (DPP)

Share Price Information for Dp Poland (DPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11.25
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.50 (4.545%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 11.25
DPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Hardman & Co Research: DP Poland (DPP): Fully proven model rolls out

18 Sep 2018 07:19

Hardman & Co Research Hardman & Co Research: DP Poland (DPP): Fully proven model rolls out 18-Sep-2018 / 07:15 GMT/BST


Hardman & Co: Fully proven model rolls out

DP Poland (DPP) has proved that the Domino's formula works as well in Poland as it does elsewhere in the world; its mature stores are substantially profitable. With 60 stores now open in Poland but only seven mature corporately owned stores, the strength of the operation does not show up in the group profit figures. The remarkable thing about the Domino's franchise is the seemingly endless growth in same-store sales. DPP has laid the foundations of a very substantial business but, so far, there is little showing above the surface. We believe it will - in time. Please click here for the full report:

http://hardmanandco.com/docs/default-source/company-docs/dp-poland-plc-documents/18.09.18-fully-proven-model-rolls.pdf

To contact us: Hardman & Co 35 New Broad Street London EC2M 1NH www.hardmanandco.comFollow us on Twitter @HardmanandCo Contacts: Jason Streets +44 20 7194 7622 js@hardmanandco.com

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: For the past 21 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the world with high-quality research, investor engagement programmes and advisory services.

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.

Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

724475 18-Sep-2018 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
21st Apr 20227:00 amRNSTrading Update
5th Apr 20227:00 amRNSBoard Changes
4th Apr 20223:33 pmRNSIssue of Equity and Total Voting Rights
16th Mar 202210:24 amRNSHolding(s) in Company
9th Mar 20227:00 amRNSNotification of Trading Update
1st Mar 20227:00 amRNSGrant of Options, Equity Issue, PDMR Dealing & TVR
18th Jan 20227:00 amRNSExercise of Options & Total Voting Rights
17th Jan 20227:00 amRNSTrading Update
31st Dec 20217:00 amRNSNotice of Trading Update
2nd Dec 20217:00 amRNSDirector Change
9th Nov 20214:27 pmRNSChange of Registered Office
9th Nov 20214:24 pmRNSHolding(s) in Company
3rd Nov 20219:30 amRNSResult of Fundraising
3rd Nov 20217:00 amRNSClose of Bookbuild
2nd Nov 202110:13 amRNSProposed Fundraising
1st Sep 20217:00 amRNSNotice of Interim Results
19th Aug 20214:41 pmRNSSecond Price Monitoring Extn
19th Aug 20214:35 pmRNSPrice Monitoring Extension
30th Jul 202111:00 amRNSResult of AGM
13th Jul 20217:00 amRNSTrading Update
9th Jul 20217:00 amRNSNotice of Trading Update and Investor presentation
28th Jun 202110:18 amRNSDirector/PDMR Shareholding
23rd Jun 20219:00 amRNSPosting of Annual Report and Notice of AGM
18th Jun 202110:02 amRNSReplacement: Final Results and Trading Update
18th Jun 20217:00 amRNSFinal Results and Trading Update
2nd Jun 20213:52 pmRNSChange of Registered Office
31st Mar 20217:00 amRNSFull year unaudited trading update for 2020
19th Mar 20214:47 pmRNSIssue of Equity and Total Voting Rights
15th Mar 20214:28 pmRNSIssue of Equity and Total Voting Rights
1st Mar 20215:30 pmRNSAppointment of Chief Financial Officer
3rd Feb 20217:00 amRNSIssue of Equity and Total Voting Rights
27th Jan 20215:32 pmRNSHolding(s) in Company
21st Jan 20217:00 amRNSNotice of Trading Update
12th Jan 20215:22 pmRNSHolding(s) in Company
11th Jan 20216:21 pmRNSHolding(s) in Company
8th Jan 20213:26 pmRNSHolding(s) in Company
8th Jan 20219:31 amRNSCompletion of Acquisition and Admission
7th Jan 202111:29 amRNSResult of GM, Issue of Equity and Board Changes
23rd Dec 20202:11 pmRNSShare Issue and Total Voting Rights
22nd Dec 20208:00 amRNSSchedule One - DP Poland PLC
21st Dec 20203:30 pmRNSRestoration - DP Poland plc
21st Dec 20203:00 pmRNSPublication of Admission Document
18th Dec 20205:51 pmRNSResult of Fundraising
18th Dec 202011:26 amRNSClose of Bookbuild
18th Dec 20207:00 amRNSProposed Fundraising and Acquisition
16th Nov 20207:00 amRNSResignation of CEO
30th Oct 20207:00 amRNSInterim results for the half year to 30 June 2020
19th Oct 20206:18 pmRNSUpdate on Possible Transaction
1st Oct 202010:39 amRNSHolding(s) in Company
1st Sep 20207:00 amRNSNotice of Interim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.